46 results on '"Hegi, Monika"'
Search Results
2. EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection
3. DNAR-07. BET PROTEIN INHIBITION SENSITIZES GLIOBLASTOMA CELLS TO TEMOZOLOMIDE TREATMENT BY ATTENUATING MGMT EXPRESSION
4. Highlights from the Literature
5. MGMT testing always worth an emotion
6. OTME-13. Integration of metabolic and transcriptional signatures of glioblastoma invasion reveals extracellular matrix reorganization and vasculature remodeling
7. BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma
8. Highlights from the Literature
9. Highlights from the Literature
10. Highlights from the Literature
11. The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
12. Highlights from the Literature
13. CBIO-13. EPIGENETIC DEREGULATION OF NUCLEAR TRANSLOCATION - A NOVEL MECHANISM FOR TREATMENT RESISTANCE IN GLIOBLASTOMA
14. COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT
15. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
16. Highlights from the Literature
17. Highlights from the Literature
18. Highlights from the Literature
19. Highlights from the Literature
20. CBMT-15. METABOLIC AND TRANSCRIPTIONAL PROFILES OF GBM INVASION: COMPARISON OF PATIENTS AND PAIRED PATIENT DERIVED XENOGRAFTS USING1H MAGNETIC RESONANCE SPECTROSCOPY AND IMAGING (7T AND 14T) AND RNA-SEQUENCING
21. MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
22. Highlights from the Literature
23. Toward methylation-based classification of central nervous system tumors
24. PATH-53. EXPRESSION BASED INTRINSIC GLIOMA SUBTYPES ARE PROGNOSTIC IN LOW GRADE GLIOMAS OF THE EORTC22033-26033 CLINICAL TRIAL
25. Highlights from the Literature
26. Correlation of immune phenotype with IDH mutation in diffuse glioma
27. Highlights from the Literature
28. Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
29. Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?
30. DRES-09. MECHANISMS OF RESISTANCE TO EGFR INHIBITION REVEAL METABOLIC VULNERABILITIES IN HUMAN GBM
31. Highlights from the Literature
32. ATCT-08THE IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA: A SECONDARY ANALYSIS OF EORTC AND NRG ONCOLOGY/RTOG
33. CSIG-05THE UBIQUITIN SPECIFIC PEPTIDASE 15 (USP15) SUPPRESSES PROLIFERATION OF HUMAN GLIOBLASTOMA CELL LINES VIA STABILIZATION OF HECTD1 E3 LIGASE
34. ATNT-10DOES VALPROIC ACID IMPROVE SURVIVAL IN GLIOBLASTOMA? A META-ANALYSIS OF RANDOMIZED TRIALS IN NEWLY DIAGNOSED GLIOBLASTOMA
35. Withholding temozolomide in glioblastoma patients with unmethylatedMGMTpromoter—still a dilemma?: Table 1.
36. Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
37. Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
38. Highlights from the Literature
39. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
40. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence
41. Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival
42. Determination of p53 Mutations, EGFR Overexpression, and Loss of p16 Expression in Pediatric Glioblastomas
43. Identical Mutations of the p53 Tumor Suppressor Gene in the Gliomatous and the Sarcomatous Components of Gliosarcomas Suggest a Common Origin from Glial Cells
44. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator
45. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice
46. Detection by 32P-postlabeling of thymidine glycol in γ-irradiated DNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.